Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by Grantham Mayo Van Otterloo & Co. LLC

Grantham Mayo Van Otterloo & Co. LLC boosted its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 12.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,974,248 shares of the pharmacy operator’s stock after buying an additional 325,721 shares during the quarter. Grantham Mayo Van Otterloo & Co. LLC owned 0.34% of Walgreens Boots Alliance worth $27,750,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in WBA. First Financial Corp IN boosted its position in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares in the last quarter. Golden State Wealth Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at about $26,000. Riverview Trust Co grew its position in shares of Walgreens Boots Alliance by 123.8% in the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after purchasing an additional 1,590 shares during the last quarter. Venturi Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance during the 4th quarter worth approximately $28,000. Finally, TD Private Client Wealth LLC raised its position in shares of Walgreens Boots Alliance by 8,670.3% during the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 3,208 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have commented on WBA shares. Bank of America increased their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Truist Financial dropped their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Evercore ISI upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. Royal Bank of Canada boosted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Finally, StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a research report on Thursday. They set a “hold” rating on the stock. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $10.59.

Walgreens Boots Alliance Price Performance

Shares of Walgreens Boots Alliance stock opened at $10.68 on Friday. The business’s fifty day moving average price is $10.75 and its 200 day moving average price is $9.98. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $19.48. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $9.23 billion, a P/E ratio of -1.04, a PEG ratio of 1.31 and a beta of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter in the previous year, the business earned $0.66 EPS. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. As a group, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.